ArticleInfection and drug resistance2022

More Than Three-Fourths of AstraZeneca (ChAdox1 COV-19) COVID-19 Vaccinated Individuals Develop Post Immunization Adverse Event in Northwest Ethiopia.

Atalay Goshu Muluneh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.